Enzo BML-SE721-0100 TRAIL (soluble) (human), (recombinant) (His-tag) (100 µg)
| Alternative Name | Apo-2L, TNFSF 10, CD253 |
|---|---|
| Biological Activity | Induces apoptosis in U937 cells at 1µg/ml, within 5 hours. At 0.5-2.0µg/ml, induces apoptosis in various thyroid carcinoma lines within 18 hours. User must determine optimal concentrations and time course for induction. Please note that this protein does not require a cross-linking enhancer to exhibit this potent activity. |
| Endotoxin Content | <0.1 EU/µg TRAIL, determined using chromogenic Limulus amebocyte lysate (LAL) test. |
| Formulation | Liquid. In PBS, containing 10% glycerol and 0.1mM DTT. |
| MW | ~23kDa |
| Purity | ≥95% (SDS-PAGE) |
| Purity Detail | Purified by multi-step chromatography. |
| Source | Produced in E. coli. Human TRAIL (aa 114-281) is fused to a His-tag. |
| Specificity | Binds to human and mouse TRAIL receptors and human osteoprotegerin (OPG). |
| UniProt ID | P50591 |
| Use/Stability | When stored at -80°C, this protein is stable at the concentration supplied, in its current storage buffer. Procedures such as dilution of the protein, followed by refreezing, could lead to loss of activity. |
| Handling | After initial defrost, aliquot product into individual tubes and refreeze at -70°C. Avoid freeze/thaw cycles. |
| Long Term Storage | -80°C |
| Shipping | Dry Ice |
| Brand | Enzo |
|---|---|
| UNSPSC | 12352202 |